Study guide
22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema
UEMS European Board of Dermatovenereology Diploma Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Eligibility & Examination Regulations
1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition
2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology
2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns
3 Chapter 3: Dermatopathology & Diagnostic Procedures
3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy
4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology
4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance
5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease
5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders
6 Chapter 6: Hair, Nails & Pigmentary Disorders
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation
7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease
7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses
8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease
8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease
9 Chapter 9: Autoimmune Bullous Diseases
9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis
10 Chapter 10: Eczematous Disorders, Urticaria & Allergology
10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy
11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis
11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses
12 Chapter 12: Paediatric & Genetic Dermatology
12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa
13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections
13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections
14 Chapter 14: Viral & Fungal Cutaneous Infections
14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses
15 Chapter 15: Sexually Transmitted Infections & Genital Infections
15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis
16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine
16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems
17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours
17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases
18 Chapter 18: Melanocytic Naevi & Melanoma
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma
19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas
19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas
20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing
20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy
21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures
21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy
22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision
22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review
22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema
Key Takeaways Explain This Topic AI
Primary Raynaud phenomenon is symmetric, starts in young people, and has normal nailfold capillaries and no digital ulcers, whereas secondary Raynaud, most often due to systemic sclerosis, shows abnormal capillaroscopy.
Nifedipine or another dihydropyridine calcium channel blocker is first-line drug treatment for Raynaud phenomenon, after warmth and stopping smoking.
Superficial vein thrombosis at least 5 cm long and more than 3 cm from the saphenofemoral junction is treated with fondaparinux 2.5 mg daily for 45 days, based on the CALISTO trial.
Livedoid vasculopathy causes painful ankle ulcers that heal as porcelain-white atrophie blanche scars and is treated with anticoagulation, for example rivaroxaban.
A positive Stemmer sign (inability to pinch the skin at the base of the second toe) indicates lymphoedema, whereas lipoedema is symmetric, painful, spares the feet, and has a negative Stemmer sign.
Last updated: September 2026
- 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema
- Peripheral Arterial Disease (PAD)
Atherosclerotic PAD shares risk factors with coronary disease: smoking, diabetes, hypertension, dyslipidaemia, age, and chronic kidney disease.
- Fontaine Stage Features
- I Asymptomatic
- II Intermittent claudication (IIa over 200 m walking distance; IIb under 200 m)
- III Ischaemic rest pain, often at night, relieved by hanging the leg down
- IV Ulceration or gangrene
The ankle-brachial pressure index is covered in the phlebology section. In diabetes and chronic kidney disease, calcified arteries can give a falsely high ABPI (over about 1.3), so toe pressures or transcutaneous oxygen measurements are used.
Arterial ulcers are painful, punched out, and on the toes, heels, or shins, with cold, pale, hairless skin and absent pulses.
Management: stop smoking, antiplatelet therapy, statins, blood pressure and diabetes control, supervised exercise, and revascularisation for limb-threatening ischaemia. High compression is contraindicated in significant arterial disease.
Raynaud Phenomenon
Episodic, cold- or stress-induced vasospasm of the digits, with a colour sequence of white (ischaemia), blue (cyanosis), and red (reperfusion) .
- Feature Primary Raynaud Secondary Raynaud
- Onset Teens to 20s, mostly women Often later
- Pattern Symmetric, mild May be asymmetric, severe
- Digital ulcers or pitting scars Absent Common
- Nailfold capillaroscopy Normal Abnormal (giant capillaries, haemorrhages, capillary loss)
- Antinuclear antibodies Negative Often positive
Causes — Systemic sclerosis (over 90% of patients have Raynaud), SLE, dermatomyositis, Sjögren syndrome, vibration injury, drugs (beta-blockers, ergots, chemotherapy such as bleomycin and cisplatin), cryoglobulinaemia, thoracic outlet syndrome
Capillaroscopy in systemic sclerosis shows early, active, and late patterns: giant capillaries and microhaemorrhages, then capillary loss and disorganised new vessels.
Treatment:
Keep the whole body warm, wear gloves, and stop smoking ; avoid triggering drugs.
Dihydropyridine calcium channel blockers (nifedipine, amlodipine) are first-line drugs.
Alternatives and additions: PDE5 inhibitors (sildenafil), topical nitrates, and angiotensin receptor blockers.
Severe attacks and digital ulcers: IV iloprost . Bosentan reduces new digital ulcers in systemic sclerosis. Botulinum toxin injections and digital sympathectomy are used in refractory cases.
Livedo
Type Appearance Meaning
Livedo reticularis (including physiological cutis marmorata) Regular, complete violet rings like a net, often disappearing on warming Usually benign vasospasm
Livedo racemosa Irregular, broken rings, persistent, often widespread Organic vessel disease: antiphospholipid syndrome , Sneddon syndrome (livedo racemosa with strokes), polyarteritis nodosa, cholesterol emboli, calciphylaxis, cryoglobulinaemia
Livedoid Vasculopathy
A non-inflammatory thrombo-occlusive disease of small dermal vessels, often with a hypercoagulable state.
Clinical: very painful purpuric macules and small ulcers around the ankles and feet , often worse in summer , healing as porcelain-white stellate scars with telangiectasia ( atrophie blanche ) and livedo.
Histology: fibrin in the walls and lumen of dermal vessels, without true vasculitis.
Work-up: thrombophilia screen, including antiphospholipid antibodies.
Treatment: anticoagulation , for example rivaroxaban (supported by a German trial), antiplatelet drugs, pentoxifylline, and IVIG in refractory disease, with pain control and compression if arterial flow allows.
Superficial Vein Thrombosis (Superficial Thrombophlebitis)
A tender red cord along a superficial vein, often a varicose vein.
Duplex ultrasound is advised, because deep vein thrombosis coexists in about a quarter of patients.
Treatment: a thrombosis at least 5 cm long and more than 3 cm from the saphenofemoral junction is treated with fondaparinux 2.5 mg daily for 45 days (CALISTO trial), plus analgesia and compression. A thrombus within 3 cm of the junction is treated as a deep vein thrombosis .
Recurrent or migratory thrombophlebitis without varicose veins should prompt a search for cancer (Trousseau syndrome) , thrombophilia, Behçet disease , and thromboangiitis obliterans (Buerger disease) , which affects young male smokers with distal ischaemia and needs complete smoking cessation. Mondor disease is thrombophlebitis of veins on the chest wall or penis.
Deep Vein Thrombosis (DVT)
Diagnosis: clinical probability (Wells score), D-dimer, and compression ultrasound .
Treatment: direct oral anticoagulants (rivaroxaban, apixaban) or low-molecular-weight heparin for at least 3 months. Compression relieves symptoms.
Post-thrombotic syndrome: chronic leg pain, oedema, pigmentation, and ulceration after DVT, leading to chronic venous insufficiency.
Thrombophilia and the Skin
Inherited: factor V Leiden (the most common inherited thrombophilia in Europeans), prothrombin G20210A, and deficiencies of protein C, protein S, and antithrombin.
Acquired: antiphospholipid syndrome (lupus anticoagulant, anticardiolipin, or anti-beta-2-glycoprotein I antibodies, persistent for at least 12 weeks), cancer, pregnancy, and oestrogens.
Skin signs: livedo racemosa, skin necrosis and ulcers, splinter haemorrhages, and warfarin-induced skin necrosis (painful necrosis of fatty areas in the first days of warfarin, especially in protein C deficiency). Homozygous protein C deficiency causes neonatal purpura fulminans .
Erythromelalgia and Other Acral Disorders
Erythromelalgia: episodes of burning pain, redness, and heat of the feet or hands, triggered by warmth and relieved by cooling. Primary forms are caused by gain-of-function SCN9A mutations (sodium channel Nav1.7). Secondary erythromelalgia is linked to myeloproliferative neoplasms (essential thrombocythaemia, polycythaemia vera), where it responds to aspirin . Patients should avoid soaking in ice water, which can cause ulceration.
Acrocyanosis: persistent painless blue-red discolouration of the hands and feet, worse in cold.
Cholesterol embolisation: livedo racemosa, "blue toes", and ulcers after arterial catheterisation or anticoagulation, with eosinophilia and kidney injury.
Lymphoedema
Type Examples
Primary Milroy disease (congenital, FLT4 / VEGFR3 ), lymphoedema-distichiasis ( FOXC2 , extra row of eyelashes), Meige disease (onset around puberty)
Secondary Cancer surgery and radiotherapy (axillary or inguinal node dissection), recurrent cellulitis , obesity, chronic venous disease (phlebolymphoedema), immobility, and worldwide filariasis ( Wuchereria bancrofti ) and podoconiosis
Stemmer sign: inability to pinch a fold of skin at the base of the second toe (or middle finger) indicates lymphoedema.
International Society of Lymphology stages: 0 latent (subclinical); I pitting oedema that improves with elevation; II oedema that does not resolve with elevation, with fibrosis; III lymphostatic elephantiasis with skin changes such as papillomatosis and hyperkeratosis ( elephantiasis nostras verrucosa ).
Investigations: lymphoscintigraphy or indocyanine green lymphography when the diagnosis is unclear.
Management: complex decongestive therapy (manual lymphatic drainage, multilayer short-stretch bandaging, exercise, and skin care), then flat-knitted compression garments . Prevent cellulitis with skin care and prophylactic penicillin after repeated episodes. Surgical options include lymphovenous anastomosis, lymph node transfer, and liposuction for fat-dominant disease.
Complications: recurrent cellulitis and, rarely, lymphangiosarcoma (Stewart-Treves syndrome) in long-standing lymphoedema.
Lipoedema
Affects women , usually starting around puberty, pregnancy, or menopause.
Symmetric excess fat of the legs (and often arms) that spares the feet and hands , giving a "cuff" at the ankles.
Tender, painful, and easily bruised; Stemmer sign is negative unless secondary lymphoedema develops.
Does not respond well to dieting. Management includes compression, exercise, weight management, psychological support, and liposuction in selected patients.